Clinical Trial Update: Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing efficacy and safety of lanreotide versus placebo for digestive fistulae.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive Fistula

Drugs mentioned

• Lanreotide (lanreotide)

Snippet

Sponsor: Ipsen | Conditions: Digestive Fistulae | Phase 3 | Status: COMPLETED